Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Sanofi opens digital biologics manufacturing facility in US

    Sanofi opens digital biologics manufacturing facility in US

    Farhat Nasim16 Oct 2019 9:45 AM IST
    The facility in Framingham accelerates the recent transformation of Sanofi's Industrial Affairs organization to focus on biologics-based therapies, in...
    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management

    Farhat Nasim16 Oct 2019 9:40 AM IST
    New Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
    Allergan shareholders okays USD 63 billion AbbVie acquisition

    Allergan shareholders okays USD 63 billion AbbVie acquisition

    Medical Dialogues Bureau15 Oct 2019 9:30 AM IST
    Under the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity...
    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Farhat Nasim14 Oct 2019 1:36 PM IST
    While two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 1:13 PM IST
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Medical Dialogues Bureau12 Oct 2019 11:41 AM IST
    The US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
    GSK collaborates with Lyell Immunopharma on cancer cell therapies

    GSK collaborates with Lyell Immunopharma on cancer cell therapies

    Medical Dialogues Bureau12 Oct 2019 9:15 AM IST
    Combining GSK plc's strong cell and gene therapy programmes with Lyell's technologies may allow the joint research team to maximize the activity and...
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 10:00 AM IST
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Farhat Nasim11 Oct 2019 9:30 AM IST
    New Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Medical Dialogues Bureau11 Oct 2019 9:15 AM IST
    Torrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

    Farhat Nasim10 Oct 2019 5:01 PM IST
    Dr Reddy's Labs' Chairman, Satish Reddy played a key role in shaping policies concerning the pharmaceutical sector as well as the economy, such as...
    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Medical Dialogues Bureau10 Oct 2019 11:34 AM IST
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok